ABC News – Top stories
·general
·1 hour ago
The company with rare licence to legally manufacture MDMA, magic mushrooms
Breathe Life Sciences holds Australia's rare license to manufacture MDMA and psilocybin for therapeutic use at its Brisbane facility, producing over 3 million products annually for more than 300 clients. The company began production in 2023 after Australia approved psychiatrist-prescribed MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression.
Summary by Glance · ABC News – Top stories
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI